Global Prostate Cancer Treatment Market Is Expected To Grow US$ 18.4 Bn By 2025 – Credence Research
The latest market report published by Credence Research, Inc. “Prostate Cancer Treatment Market – Market Growth, Future Prospects, Competitive Analysis and Pipeline Analysis, 2017 – 2025,” the prostate cancer treatment market was valued at US$5.63 Bn in 2016, and is expected to reach US$ 18.4 Bn by 2025 expanding at a CAGR of 12.3 % from 2017 to 2025.
Browse the full report Prostate Cancer Treatment Market – Market Growth, Future Prospects, Competitive Analysis, and Pipeline Analysis 2017 – 2025 at http://www.credenceresearch.com/report/prostate-cancer-treatment-market
The key risk factors for prostate cancer development is being old age, genetic, obesity and race. Around 99% of the cases for prostate cancer is most commonly seen after the age of 50 years. The currently available treatment are biological therapy and chemotherapy. Biological therapy are considered as the largest segment of prostate cancer treatment market as it is the preferred first line of treatment. Chemotherapy is an option to the patients who are resistant to the Biological therapy. The key factors assisting the growth of prostate cancer treatment market are growing prevalence of prostate cancer coupled with growing public awareness, rising healthcare expenditure in the developed and developing regions and developing technology of pharmaceutical companies leading to more target specific drugs with lesser side effects and strong emerging pipeline. On the other hand, insufficient funding in developing and under developed countries and high cost involved in the treatment of the disease are hindering the market growth of prostate cancer treatment.
The complete report is available at http://www.credenceresearch.com/report/prostate-cancer-treatment-market
Prostate Cancer Treatment Market
Pipeline of prostate cancer treatment market is dense and comprises combination of biological drugs and chemotherapy drugs. However, the no. of biological therapy molecules is more in the phase III of clinical trials compared to chemotherapy. We have estimated sales of very specific molecules based on the type (biological or chemical), disease prevalence, sponsor, depicted peak sales by leading market experts and other factors.
Key Market Movements:
Rising prevalence of prostate cancer in developed and developing countries
Aging population, in developed countries is expected to boost the market
Government and non-government initiatives to fight prostate cancer and supporting reimbursement policies
Rising public awareness with early disease diagnosis and strong emerging pipeline is expected to boost the Prostate cancer treatment market
About Credence Research:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Company Name: Credence Research
Contact Person: Chris Smith, Global Sales Manager
Email: Send Email
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
Country: United States